[Translated article] Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis

Autor:	Serra-Baldrich, E., Santamaria-Babí, L.F., Francisco Silvestre, J.
Zdroj:	In Actas dermosifiliograficas July-August 2022 113(7):T674-T684
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect